Avera Dialysis - Sioux Falls is a medicare approved dialysis facility center in Sioux Falls, South Dakota and it has 22 dialysis stations. It is located in Minnehaha county at 1315 S Cliff Ave, Sioux Falls, SD, 57105. You can reach out to the office of Avera Dialysis - Sioux Falls at (605) 322-1490. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Avera Dialysis - Sioux Falls has the following ownership type - Non-Profit. It was first certified by medicare in January, 2014. The medicare id for this facility is 430016 and it accepts patients under medicare ESRD program.
| Name | Avera Dialysis - Sioux Falls |
|---|---|
| Location | 1315 S Cliff Ave, Sioux Falls, South Dakota |
| No. of Dialysis Stations | 22 |
| Medicare ID | 430016 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 1315 S Cliff Ave, Sioux Falls, South Dakota, 57105 | |
| (605) 322-1490 | |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
| NPI Number | 1710316252 |
| Organization Name | Avera Dialysis Sioux Falls |
| Doing Business As | Avera Mckennan |
| Address | 1315 S Cliff Ave Sioux Falls, South Dakota, 57105 |
| Phone Number | (605) 322-1490 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 80 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 30 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 89 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 651 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
| Adult patients getting regular peritoneal dialysis at the center | 63 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 470 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 96 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Avera Dialysis - Sioux Falls with elevated calcium levels.
| Patients with hypercalcemia | 157 |
| Hypercalcemia patient months | 1319 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 160 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 164 |
| Patient months included in arterial venous fistula and catheter summaries | 825 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 67 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 118 |
| Hospitalization Rate in facility | 200.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 313.3 |
| Hospitalization Rate: Lower Confidence Limit | 137 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Avera Dialysis - Sioux Falls were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.5 |
| Readmission Rate: Lower Confidence Limit | 17.9 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Avera Dialysis - Sioux Falls get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.64 (As Expected) |
| SIR: Upper Confidence Limit | 2.93 |
| SIR: Lower Confidence Limit | .83 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Avera Dialysis - Sioux Falls's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 100 |
| Transfusion Rate in facility | 52.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 100.2 |
| Transfusion Rate: Lower Confidence Limit | 29.9 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Avera Dialysis - Sioux Falls lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 380 |
| Mortality Rate in facility | 15.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.2 |
| Mortality Rate: Lower Confidence Limit | 10.7 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago
Avera Dialysis - Sioux Falls Location: 1315 S Cliff Ave, Sioux Falls, South Dakota, 57105 Phone: (605) 322-1490 |
Sanford Health - Dialysis Unit Location: 1305 W 18th St, Sioux Falls, South Dakota, 57117 Phone: (605) 333-1000 |
Sioux Falls Dialysis - Davita Location: 2326 W 69th St, Sioux Falls, South Dakota, 57108 Phone: (605) 332-1262 |
News Archive
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.
Elsevier, the world-leading provider of scientific, technical and medical information products, tools and services, announced a new initiative for the Chinese market which involves the establishment of a strategic cooperation with Peking University Health Science Center School of Distance Learning for Medical Education (PUHSC).
Rainbow Coral Corp. announced today that it has established the headquarters of its new biotechnology division—Rainbow BioSciences, LLC—in Houston, Texas, home of the world's largest medical complex.
SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.
› Verified 3 days ago